Anebulo Pharmaceuticals Stock Price Patterns

ANEB Stock  USD 0.88  0.01  0.57%   
The RSI of Anebulo Pharmaceuticals' share price is below 30 at the present time. This suggests that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Anebulo Pharmaceuticals, making its price go up or down.

Momentum 24

 Sell Stretched

 
Oversold
 
Overbought
The successful prediction of Anebulo Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Anebulo Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Anebulo Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
(0.13)
EPS Estimate Current Year
(0.48)
EPS Estimate Next Year
(0.46)
Wall Street Target Price
3
EPS Estimate Current Quarter
(0.12)
Using Anebulo Pharmaceuticals hype-based prediction, you can estimate the value of Anebulo Pharmaceuticals from the perspective of Anebulo Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Anebulo Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Anebulo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Anebulo Pharmaceuticals after-hype prediction price

    
  USD 0.77  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Anebulo Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anebulo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.071.407.58
Details
Naive
Forecast
LowNextHigh
0.010.716.89
Details
2 Analysts
Consensus
LowTargetHigh
2.733.003.33
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.12-0.12-0.12
Details

Anebulo Pharmaceuticals After-Hype Price Density Analysis

As far as predicting the price of Anebulo Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Anebulo Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Anebulo Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Anebulo Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Anebulo Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Anebulo Pharmaceuticals' historical news coverage. Anebulo Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.04 and 6.95, respectively. We have considered Anebulo Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.88
0.77
After-hype Price
6.95
Upside
Anebulo Pharmaceuticals is extremely dangerous at this time. Analysis and calculation of next after-hype price of Anebulo Pharmaceuticals is based on 3 months time horizon.

Anebulo Pharmaceuticals Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Anebulo Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Anebulo Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Anebulo Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.52 
6.18
  0.11 
  0.03 
10 Events / Month
5 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.88
0.77
12.00 
8,829  
Notes

Anebulo Pharmaceuticals Hype Timeline

Anebulo Pharmaceuticals is presently traded for 0.88. The entity has historical hype elasticity of -0.11, and average elasticity to hype of competition of 0.03. Anebulo is forecasted to decline in value after the next headline, with the price expected to drop to 0.77. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -12.0%, whereas the daily expected return is presently at -1.52%. The volatility of related hype on Anebulo Pharmaceuticals is about 34333.33%, with the expected price after the next announcement by competition of 0.91. About 41.0% of the company shares are held by company insiders. The book value of Anebulo Pharmaceuticals was presently reported as 0.24. The company recorded a loss per share of 0.22. Anebulo Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days.
Check out Anebulo Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.

Anebulo Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Anebulo Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Anebulo Pharmaceuticals' future price movements. Getting to know how Anebulo Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Anebulo Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
TLSATiziana Life Sciences 0.08 8 per month 0.00 (0.06) 7.41 (5.81) 21.81 
IMMXImmix Biopharma 0.26 7 per month 4.31  0.14  15.04 (8.41) 28.79 
WHWKWhitehawk Therapeutics(0.07)7 per month 3.80  0.05  6.98 (6.67) 21.49 
ZNTLZentalis Pharmaceuticals Llc 0.04 7 per month 4.23  0.1  17.36 (9.54) 48.58 
COYACoya Therapeutics Common(0.02)4 per month 0.00 (0.14) 4.69 (5.36) 18.45 
PLRXPliant Therapeutics 0.02 5 per month 0.00 (0.16) 4.58 (6.71) 22.72 
CLNNClene Inc(0.11)13 per month 0.00 (0.1) 10.11 (15.07) 47.42 
MGNXMacroGenics 0.03 8 per month 3.78  0.02  6.83 (6.25) 23.75 
ESLAEstrella Immunopharma(0.06)5 per month 0.00 (0.1) 12.21 (15.49) 50.95 
OKYOOKYO Pharma Ltd 0.01 6 per month 0.00 (0.01) 10.99 (8.25) 34.51 

Anebulo Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Anebulo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Anebulo using various technical indicators. When you analyze Anebulo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Anebulo Pharmaceuticals Predictive Indicators

The successful prediction of Anebulo Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Anebulo Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Anebulo Pharmaceuticals based on analysis of Anebulo Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Anebulo Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Anebulo Pharmaceuticals's related companies.
 2025 2026 (projected)
PB Ratio4.84.56
Capex To Depreciation7.0E-66.0E-6

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Complementary Tools for Anebulo Stock analysis

When running Anebulo Pharmaceuticals' price analysis, check to measure Anebulo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anebulo Pharmaceuticals is operating at the current time. Most of Anebulo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Anebulo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anebulo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Anebulo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes